Replies to post #273153 on Amarin Corp Plc (AMRN)

[Whalatane]

Meo. Lets move on .
My guess on EU valuation is colored by the following

Oslo, Norway, 24 August 2012: Pronova BioPharma (OSE: PRON.OL) yesterday received notice that the Spanish Ministry of Health has decided, as part of a general measure to reduce healthcare expenditure, to discontinue reimbursement of Omacor with effect from 1 September. Pronova BioPharma and Grupo Ferrer, who holds the exclusive license to Omacor in Spain, object to the decision and are considering various actions to secure continued good access to Omacor for Spanish patients.

Emphasis is mine .
I'm concerned that Covid will have devastated many EU countries health care budgets ...and they will respond as Spain did in 2012 as a way to reduce healthcare coverage expenditures by limiting access or co pays to Vascepa .

Vtem ...if U are reading this . Loss carry forwards are generally more of interest to an acquiring BP. If AMRN was to attempt to GIA in the EU ...expect loss's for several yrs ...just my non accountant opinion
Kiwi